185 related articles for article (PubMed ID: 6690054)
1. Influence of cellular DNA content on survival in advanced ovarian cancer.
Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH
Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
3. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
Hedley DW; Rugg CA; Ng AB; Taylor IW
Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
5. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
7. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.
Hedley DW; Friedlander ML; Taylor IW
Cytometry; 1985 Jul; 6(4):327-33. PubMed ID: 4017799
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
10. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
11. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
12. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric DNA analysis in colorectal cancer].
Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry.
Huang MS; Colby TV; Therneau TM; Daly RC; Gonchoroff NJ
Cytometry; 1996 Dec; 26(4):253-9. PubMed ID: 8979023
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
19. Concordance of DNA ploidy pattern as measured by flow cytometry in primary, metastatic, and persistent ovarian carcinoma.
Zanetta GM; Keeney GL; Kimlinger TK; Katzmann JA; Podratz KC
Gynecol Oncol; 1996 Feb; 60(2):213-6. PubMed ID: 8631540
[TBL] [Abstract][Full Text] [Related]
20. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
